Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02250781 · ClinicalTrials.gov registry record · Phase 1

Oral ONC201 in Treating Patients With Advanced Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
Phase 1
Development phase
58
Enrollment target
1
Study location

NCT02250781 is a Phase 1 study of Solid Tumors that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 58 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02250781, a Phase 1 study of Solid Tumors, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
Phase 1
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

This phase I trial studies the side effects and best dose of Oral ONC201 in treating patients with advanced solid tumors. Oral ONC201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Conditions Studied

Solid Tumors

Interventions

  • DRUG Oral ONC201

Study Locations (1)

New Jersey

  • Rutgers Cancer Institute of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2015-01-12
Est. Completion 2018-10-25
Phase Phase 1

Sponsor

Rutgers, The State University of New Jersey

413 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02250781

The ClinicalTrials.gov registry entry for NCT02250781 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (80% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which Oral ONC201 is the first listed.

NCT02250781 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02250781 about?

NCT02250781 is a clinical study titled "Oral ONC201 in Treating Patients With Advanced Solid Tumors". This phase I trial studies the side effects and best dose of Oral ONC201 in treating patients with advanced solid tumors. Oral ONC201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

What is the current status of trial NCT02250781?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2015-01-12. Estimated completion is 2018-10-25.

What conditions does trial NCT02250781 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT02250781?

The interventions under investigation include: Oral ONC201 (DRUG).

Who is sponsoring clinical trial NCT02250781?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02250781 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.